DNTHDianthus Therapeutics Inc. Common Stock
111.10USD-2.29%Mkt Cap: 6.07B $P/E: —3d ago
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal ant…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap6.07B $
Enterprise Value5.24B $
Revenue (TTM)1.90M $
Gross Profit1.90M $
Net Income (TTM)-162.34M $
Revenue/Share0.0410 USD
Last Price111.10 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees92
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-23.09
PEG—
EV/EBITDA-24.07
EV/Revenue2752.02
P/S3217.11
P/B5.12
EPS (TTM)-4.09
EPS (Forward)-4.74
52W Range
20.3193% of range117.88
52W High117.88 USD
52W Low20.31 USD
Profitability
Gross Margin100.00%
Oper. Margin-8079.11%
EBITDA Margin0.00%
Profit Margin-7973.33%
ROE-32.90%
ROA-30.58%
Growth
Revenue Growth294.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-129.06M $
CapEx (TTM)213.00K $
FCF Margin-4842.99%
FCF Yield-1.52%
Net Debt-885.53M $
Net Debt/EBITDA4.07
Balance Sheet
Debt/Equity0.00
Current Ratio26.10
Quick Ratio25.79
Book Value/Sh21.39 USD
Cash/Share15.86 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)137.62 USD
Upside (mean)+23.9%
Target Range109.00 USD – 200.00 USD
$109.00+23.9% to mean$200.00
# Analysts13
Ownership
Shares Out.54.67M
Float55.85M
Insiders0.12%
Institutions128.09%
Short Interest
Short Ratio8.5d
Short % Float17.60%
Short % Out.15.29%
Shares Short8.38M
Short (prev mo.)9.53M
Technical
SMA 5099.68 (+11.5%)
SMA 20072.02 (+54.3%)
Beta0.08
S&P 52W Chg18.16%
Avg Vol (30d)778.88K
Avg Vol (10d)675.27K
Technical Indicators
RSI (14)55.2
MACD3.8657
MACD Signal4.1218
MACD Hist.-0.2561
BB Upper117.32 USD
BB Middle109.20 USD
BB Lower101.08 USD
BB Width14.87%
ATR (14)5.513 USD
Vol Ratio (20d)1.02x